DK3019180T3 - Beta-casein a2 og reduktion eller forebyggelse af symptomerne på laktoseintolerans - Google Patents

Beta-casein a2 og reduktion eller forebyggelse af symptomerne på laktoseintolerans Download PDF

Info

Publication number
DK3019180T3
DK3019180T3 DK14823628.4T DK14823628T DK3019180T3 DK 3019180 T3 DK3019180 T3 DK 3019180T3 DK 14823628 T DK14823628 T DK 14823628T DK 3019180 T3 DK3019180 T3 DK 3019180T3
Authority
DK
Denmark
Prior art keywords
casein
symptoms
beta
prevention
reduction
Prior art date
Application number
DK14823628.4T
Other languages
English (en)
Inventor
Malav Suchin Trivedi
Andrew John Clarke
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52280344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3019180(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Application granted granted Critical
Publication of DK3019180T3 publication Critical patent/DK3019180T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
DK14823628.4T 2013-07-12 2014-07-10 Beta-casein a2 og reduktion eller forebyggelse af symptomerne på laktoseintolerans DK3019180T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361845480P 2013-07-12 2013-07-12
PCT/NZ2014/000141 WO2015005804A1 (en) 2013-07-12 2014-07-10 Beta-casein a2 and reducing or preventing symptoms of lactose intolerance

Publications (1)

Publication Number Publication Date
DK3019180T3 true DK3019180T3 (da) 2019-08-26

Family

ID=52280344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14823628.4T DK3019180T3 (da) 2013-07-12 2014-07-10 Beta-casein a2 og reduktion eller forebyggelse af symptomerne på laktoseintolerans

Country Status (21)

Country Link
US (3) US20160136238A1 (da)
EP (2) EP3542805A1 (da)
JP (2) JP6436592B2 (da)
KR (2) KR102367941B1 (da)
CN (3) CN105431156A (da)
AU (2) AU2014287862B2 (da)
BR (1) BR112016000612B8 (da)
CA (2) CA2917492C (da)
CL (1) CL2016000064A1 (da)
DK (1) DK3019180T3 (da)
ES (1) ES2743194T3 (da)
HK (1) HK1223846A1 (da)
IL (2) IL243366B (da)
MX (2) MX368912B (da)
MY (2) MY190309A (da)
NZ (2) NZ754642A (da)
PH (2) PH12016500032B1 (da)
RU (1) RU2671562C2 (da)
SG (2) SG11201510707YA (da)
WO (1) WO2015005804A1 (da)
ZA (1) ZA201600007B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024975B1 (pt) 2015-05-22 2022-03-15 The A2 Milk Company Limited Uso de leite bovino contendo beta-caseína
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
MX2018011817A (es) 2016-03-30 2019-01-24 A2 Milk Co Ltd Beta-caseinas y la funcion cognitiva.
CA3036494C (en) 2016-09-30 2022-10-18 The A2 Milk Company Limited Beta-caseins and gut microbiota
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442585T1 (de) 1994-11-04 2009-09-15 A2 Corp Ltd Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte
US7094949B2 (en) * 1995-05-16 2006-08-22 A2 Corporation Limited Breeding and milking cows for milk free of β-casein A1
WO1996036239A1 (en) 1995-05-16 1996-11-21 Corran Norman Stuart Mclachlan Food product and process
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
WO2001000047A1 (en) * 1999-06-29 2001-01-04 The New Zealand Milk Institute Limited Prophylactic dietary supplement based on milk
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
DK1663298T3 (da) * 2003-09-23 2019-10-14 Dsm Ip Assets Bv Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner
CN1899054A (zh) * 2006-07-17 2007-01-24 颜贻谦 去糖牛奶的制作方法
JP2012522505A (ja) * 2009-04-03 2012-09-27 ネステク ソシエテ アノニム ミルク様飲料
AU2010238184B2 (en) * 2009-04-15 2014-09-04 Glanbia Nutritionals (Ireland) Limited A reduced lactose milk product and a process for the preparation thereof
DE102010009582A1 (de) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
CN103315063A (zh) * 2012-03-19 2013-09-25 基斯有限公司 可预防疾病的婴儿配方奶粉
CN106455662A (zh) * 2014-06-03 2017-02-22 雅培制药有限公司 包含亲脂性活性成分的营养组合物

Also Published As

Publication number Publication date
RU2015156804A (ru) 2017-08-17
CL2016000064A1 (es) 2016-12-16
BR112016000612A2 (da) 2017-07-25
BR112016000612B1 (pt) 2021-11-03
NZ715985A (en) 2022-09-30
MY190309A (en) 2022-04-13
IL261143B (en) 2021-02-28
JP6436592B2 (ja) 2018-12-12
CN114832092A (zh) 2022-08-02
WO2015005804A1 (en) 2015-01-15
AU2019203684B2 (en) 2021-08-05
ES2743194T3 (es) 2020-02-18
KR102291660B1 (ko) 2021-08-19
JP2016523958A (ja) 2016-08-12
JP6990154B2 (ja) 2022-01-12
AU2014287862B2 (en) 2019-07-11
EP3542805A1 (en) 2019-09-25
EP3019180A1 (en) 2016-05-18
PH12016500032A1 (en) 2016-03-28
US20200147173A1 (en) 2020-05-14
MX368912B (es) 2019-10-21
PH12019550112A1 (en) 2020-09-14
AU2014287862A1 (en) 2016-02-11
RU2015156804A3 (da) 2018-05-31
MY172939A (en) 2019-12-16
AU2019203684A1 (en) 2019-06-20
SG11201510707YA (en) 2016-01-28
PH12016500032B1 (en) 2016-03-28
MX2016000308A (es) 2016-11-14
HK1223846A1 (zh) 2017-08-11
IL261143A (en) 2018-10-31
US20220175882A1 (en) 2022-06-09
CN105431156A (zh) 2016-03-23
KR102367941B1 (ko) 2022-02-24
RU2018131604A3 (da) 2022-04-19
CA2917492C (en) 2023-11-14
US20160136238A1 (en) 2016-05-19
RU2671562C2 (ru) 2018-11-02
BR112016000612B8 (pt) 2022-02-22
MX2019012446A (es) 2020-02-03
JP2018203753A (ja) 2018-12-27
CN110800803A (zh) 2020-02-18
IL243366B (en) 2018-11-29
KR20160030974A (ko) 2016-03-21
KR20200085375A (ko) 2020-07-14
RU2018131604A (ru) 2018-11-20
EP3019180A4 (en) 2017-03-08
EP3019180B1 (en) 2019-05-29
SG10201710237PA (en) 2018-01-30
CA3214545A1 (en) 2015-01-15
NZ754642A (en) 2022-09-30
ZA201600007B (en) 2017-11-29
CA2917492A1 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
NO2023013I1 (no) Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent
DK3019180T3 (da) Beta-casein a2 og reduktion eller forebyggelse af symptomerne på laktoseintolerans
IL262302B (en) Beta-casein a2 and prevention of intestinal inflammation
ITUB20156293A1 (it) Circuito integrato con trincea isolata e relativi metodi
DK3380313T3 (da) Forbedringer vedrørende fremstillingen af vindmøllevinger
DE112016005486A5 (de) Sicherheitselement und mit demselben ausgestatteter Datenträger
ZA201903810B (en) Gremlin-1 crystal structure and inhibitory antibody
DK3094923T3 (da) Konstruktionselement med mindst én elektronisk komponent og tilhørende fremgangsmåde
DK3019129T3 (da) Øjenmaske til bedring eller forebyggelse af tørre øjne og lignende
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
IT201600078969A1 (it) Integratore alimentare
GB201510606D0 (en) Integrated circuit inputs and outputs
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3197556T3 (da) Sammensætning til forebyggelse og/eller behandling af allergisymptomer
DK3212182T3 (da) Behandling eller forebyggelse af anæmi i drægtige ikke-humane pattedyr og afkom
DK3060660T3 (da) Rekombinante glycoproteiner og anvendelser deraf
DK3440752T3 (da) Indsatshalvdel og indsatsblok omfattende to af nævnte indsatshalvdele
DK3237777T3 (da) Forbedringer af eller i forbindelse med spændeanordninger
DK3209889T3 (da) Forbedringer i eller angående forbindelsesindretninger
DK3021858T3 (da) Stamme cu1 til behandling og/eller forebyggelse af kronisk, inflammatorisk reumatisme
DK2976089T3 (da) Anvendelse af sedoheptulose til forebyggelse eller behandling af inflammation
JP2016068332A5 (ja) 積層板および化粧板
TH1601000120A (th) เบต้า-เคซีน a2 เเละการลด หรือป้องกันอาการของการเเพ้เเลคโตส
DK3532428T3 (da) Forbedringer af eller i forbindelse med sadler
FI11556U1 (fi) Lamellihirsi